Adaptive Biotechnologies Corp

ADPT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
107
SEC Filings

Business Summary

PART I Overview Throughout our history, we have advanced the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is natures most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read th...

Next Earnings

Q2 FY2026 — expected 2026-08-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionADPTdiscussed_in_filing Cybersecurity
topic_mentionADPTdiscussed_in_filing Cybersecurity
topic_mentionADPTdiscussed_in_filing Healthcare & Bio
topic_mentionADPTdiscussed_in_filing Platform & Ecosystem
topic_mentionADPTdiscussed_in_filing Healthcare & Bio
topic_mentionADPTdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076902EDGAR86K words
2025-03-032024-12-310000950170-25-030913EDGAR—
2024-02-292023-12-310000950170-24-023095EDGAR—
2023-02-142022-12-310000950170-23-002792EDGAR—
2022-02-152021-12-310001564590-22-005228EDGAR—
2021-02-242020-12-310001564590-21-008124EDGAR—
2020-02-262019-12-310001564590-20-006830EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-267061EDGAR28K words
2025-08-052025-06-300000950170-25-103120EDGAR—
2025-05-012025-03-310000950170-25-061897EDGAR—
2024-11-072024-09-300000950170-24-123423EDGAR—
2024-08-012024-06-300000950170-24-089342EDGAR—
2024-05-072024-03-310000950170-24-054604EDGAR—
2023-11-092023-09-300000950170-23-062136EDGAR—
2023-08-022023-06-300000950170-23-037234EDGAR—
2023-05-032023-03-310000950170-23-017250EDGAR—
2022-11-032022-09-300000950170-22-021923EDGAR—
2022-08-032022-06-300001564590-22-027784EDGAR—
2022-05-042022-03-310001564590-22-017870EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-050001193125-26-039409EDGAR4K words
2026-01-120001193125-26-009840EDGAR—
2025-12-300001193125-25-335921EDGAR—
2025-11-050001193125-25-266974EDGAR—
2025-08-180001193125-25-182222EDGAR—
2025-08-050000950170-25-103058EDGAR—
2025-06-120001193125-25-140017EDGAR—
2025-05-010000950170-25-061851EDGAR—
2025-02-110000950170-25-017915EDGAR—
2024-11-070000950170-24-123369EDGAR—

107 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001478320
TickerADPT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedWA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 850f6ebfe437bbdfdc9f9b1d6ed17055d9368c4e865704c2f29e9f13ad7fa7d1
parent: f7452ac84ad10018b2c2ae03b0713807d5b7a51a95b07c347d4ad0ac1c0e42bc
content hash: d30041ac04ec323c8ef44962704c304c0fac0bd3f68f0c60290c972add268346
signed: 2026-04-13T04:43:28.442Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf